An ILK/STAT3 pathway controls glioblastoma stem cell plasticity
Developmental Cell · 2024
DOI: 10.1016/j.devcel.2024.09.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Cell, 2024. Verfasst von Alexander E P Loftus und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research UK Scotland Centre (Edinburgh), Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XU, UK. E…. Hauptthemen laut MEDLINE: Glioblastoma, Protein Serine-Threonine Kinases, Neoplastic Stem Cells, STAT3 Transcription Factor. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Cancer Research UK, Brain Tumor Charity.
Abstract (Originalsprache)
Glioblastoma (GBM) is driven by malignant neural stem-like cells that display extensive heterogeneity and phenotypic plasticity, which drive tumor progression and therapeutic resistance. Here, we show that the extracellular matrix-cell adhesion protein integrin-linked kinase (ILK) stimulates phenotypic plasticity and mesenchymal-like, invasive behavior in a murine GBM stem cell model. ILK is required for the interconversion of GBM stem cells between malignancy-associated glial-like states, and its loss produces cells that are unresponsive to multiple cell state transition cues. We further show that an ILK/STAT3 signaling pathway controls the plasticity that enables transition of GBM stem cells to an astrocyte-like state in vitro and in vivo. Finally, we find that ILK expression correlates with expression of STAT3-regulated proteins and protein signatures describing astrocyte-like and mesenchymal states in patient tumors. This work identifies ILK as a pivotal regulator of multiple malignancy-associated GBM phenotypes, including phenotypic plasticity and mesenchymal state.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Research UK Scotland Centre (Edinburgh), Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XU, UK. Electronic address: a.loftus@ed.ac.uk.
- Cancer Research UK Scotland Centre (Edinburgh), Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XU, UK.
- Department of Molecular Biotechnology and Health Science, University of Torino, Via Nizza 52, 10126 Torino, Italy.
- MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XU, UK.
- Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YG, UK.
- Division of Molecular and Cellular Function, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, UK.
Förderung
- Medical Research Council
- Cancer Research UK
- Brain Tumor Charity
- Wellcome Trust
- UK Research and Innovation Medical Research Council
Zitieren
APA
Loftus, A. E. P., Romano, M. S., Phuong, A. N., McKinnel, B. J., Muir, M. T., Furqan, M., Dawson, J. C., Avalle, L., Douglas, A. T., Mort, R. L., Byron, A., Carragher, N. O., Pollard, S. M., Brunton, V. G., & Frame, M. C. (2024). An ILK/STAT3 pathway controls glioblastoma stem cell plasticity. Developmental Cell. https://doi.org/10.1016/j.devcel.2024.09.003
Vancouver
Loftus AEP, Romano MS, Phuong AN, McKinnel BJ, Muir MT, Furqan M, et al. An ILK/STAT3 pathway controls glioblastoma stem cell plasticity. Developmental Cell. 2024. doi:10.1016/j.devcel.2024.09.003
BibTeX
@article{Loftus2024,
author = {Loftus, Alexander E P and Romano, Marianna S and Phuong, Anh Nguyen and McKinnel, Ben J and Muir, Morwenna T and Furqan, Muhammad and Dawson, John C and Avalle, Lidia and Douglas, Adam T and Mort, Richard L and Byron, Adam and Carragher, Neil O and Pollard, Steven M and Brunton, Valerie G and Frame, Margaret C},
title = {An ILK/STAT3 pathway controls glioblastoma stem cell plasticity},
journal = {Developmental Cell},
year = {2024},
doi = {10.1016/j.devcel.2024.09.003}
}
EUVIMED